United Kingdom Biotechnology & Medical Research

IXICO PLC (IXI)

Track

Track

IXICO PLC recorded one insider trading transaction over the past ninety days. Non-Executive Chair Mark Warne purchased shares valued at approximately 3,988 GBP. This activity occurs amid a period where the stock price has declined by 11.8 percent, following the most recent results financiers released in May 2026.
Ticker: IXI Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for IXICO PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mark Warne Non-Executive Chair Director
Transaction date
Purchase
Price
379.62
Quantity 51,801
Value £2,737,746
Grant Nash Chief Financial Officer Officer
Transaction date
Purchase
Price
261.06
Quantity 81,982
Value £4,077,696
Grant Nash Chief Financial Officer Officer
Transaction date
Sale
Price
50.34
Quantity 30,808
Value £4,681,635
Katherine Rogers Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.10
Quantity 52,631
Value £5,000
Dipti Amin Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.10
Quantity 105,263
Value £10,000
Grant Nash Chief Financial Officer Officer
Transaction date
Purchase
Price
0.10
Quantity 105,263
Value £10,000
Bram Goorden Chief Executive Officer Officer
Transaction date
Purchase
Price
0.10
Quantity 526,315
Value £50,000
Robin Wolz Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.12
Quantity 44,000
Value €5,239
Grant Nash CFO Officer
Transaction date
Purchase
Price
0.25
Quantity 200,000
Value £50,040
Grant Nash CFO Officer
Transaction date
Sale
Price
0.25
Quantity 200,000
Value £50,000
Mark Warne Non-Executive Director Executive Director
Transaction date
Purchase
Price
0.63
Quantity 14,250
Value £8,978
Charles Spicer Non-Executive Chairman Director
Transaction date
Purchase
Price
0.29
Quantity 70,175
Value £20,000
Giulio Cerroni Chief Executive Officer Officer
Transaction date
Purchase
Price
0.28
Quantity 53,300
Value £14,924
Giulio Cerroni Chief Executive Officer Officer
Transaction date
Purchase
Price
0.32
Quantity 31,550
Value £9,938
Charles Alexander Evan Spicer Non-Executive Chairman Director
Transaction date
Purchase
Price
0.33
Quantity 60,606
Value £20,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-15 B Purchase
Mark Warne

Non-Executive Chair

Director
51,801
379.62
£2,737,746 		51,801 379.62 £2,737,746
2024-12-04 2024-12-04 B Purchase Grant Nash

Chief Financial Officer

Officer
81,982
261.06
£4,077,696 		81,982 261.06 £4,077,696
2024-12-04 2024-12-04 S Sale Grant Nash

Chief Financial Officer

Officer
30,808
50.34
£4,681,635 		30,808 50.34 £4,681,635
2024-10-28 2024-10-28 B Purchase Katherine Rogers

Non-Executive Director

Executive Director
52,631
0.10
£5,000 		52,631 0.10 £5,000
2024-10-28 2024-10-28 B Purchase Dipti Amin

Non-Executive Director

Executive Director
105,263
0.10
£10,000 		105,263 0.10 £10,000
2024-10-28 2024-10-28 B Purchase Grant Nash

Chief Financial Officer

Officer
105,263
0.10
£10,000 		105,263 0.10 £10,000
2024-10-28 2024-10-28 B Purchase Bram Goorden

Chief Executive Officer

Officer
526,315
0.10
£50,000 		526,315 0.10 £50,000
2024-10-16 2024-10-15 B Purchase Robin Wolz

Chief Scientific Officer

Officer
44,000
0.12
€5,239 		44,000 0.12 €5,239
2022-12-22 2022-12-22 B Purchase Grant Nash

CFO

Officer
200,000
0.25
£50,040 		200,000 0.25 £50,040
2022-12-22 2022-12-22 S Sale Grant Nash

CFO

Officer
200,000
0.25
£50,000 		200,000 0.25 £50,000
2021-03-25 2021-03-24 B Purchase Mark Warne

Non-Executive Director

Executive Director
14,250
0.63
£8,978 		14,250 0.63 £8,978
2019-03-18 2019-03-18 B Purchase Charles Spicer

Non-Executive Chairman

Director
70,175
0.29
£20,000 		70,175 0.29 £20,000
2019-03-13 2019-03-12 B Purchase Giulio Cerroni

Chief Executive Officer

Officer
53,300
0.28
£14,924 		53,300 0.28 £14,924
2018-05-30 2018-05-29 B Purchase Giulio Cerroni

Chief Executive Officer

Officer
31,550
0.32
£9,938 		31,550 0.32 £9,938
2018-05-23 2018-05-23 B Purchase Charles Alexander Evan Spicer

Non-Executive Chairman

Director
60,606
0.33
£20,000 		60,606 0.33 £20,000
Explore more

More insider trading research around IXICO PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe